CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity Biotech Investing
Life Science Big News Roundup: Relevium’s Subsidiary Secures $1M Export Contract for the Middle East; PreveCeutical Completes its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides in a Cell-Based Brain Cancer Model Life Science Investing
